A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia
Conclusion: These data quantify the deteriorating impact of CML disease progression and the impact of nonresponse to treatment. The study results add to evidence from other disease areas that systematic differences exist in preference values between countries. (Source: Value in Health)
